EGD-assisted Bowel Preparation for Colonoscopy

NCT ID: NCT01563744

Last Updated: 2016-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

82 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-08-31

Study Completion Date

2012-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Adequate bowel preparation is of critical importance for colonoscopy. Particularly among hospitalized patients, inadequate bowel preparation for colonoscopy may arise due to patient intolerance to prescribed laxative regimen, elderly population, and co-existing conditions that impair the ability to ingest a large-volume laxative regimen. Improvements in bowel preparation for colonoscopy in hospitalized patients would likely improve patient care and reduce hospital costs. The purpose of this study is to determine if administering a portion of the bowel purgative via EGD could improve colonoscopy preparation in hospitalized patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this randomized controlled trial in hospitalized patients, patients in whom colonoscopy was anticipated the day following EGD were consented and randomized to either standard prep by mouth (split-dose PEG) or intervention group (instillation of the first 2 liters of Nulytely solution through the channel of the endoscope into the duodenal bulb, then continue standard prep). Data is collected on quality of prep and patient satisfaction in both groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Esophagoscopy Techniques Colonoscopy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EGD-assisted colonoscopy prep

2 liters of polyethylene glycol instilled through the channel of the endoscope during EGD when colonoscopy expected the following day. Patients follow a clear liquid diet, then ingest an addition 1 liter polyethylene glycol 4 hours prior to colonoscopy. Patients are also given a tap water enema 1 hour prior to colonoscopy.

Group Type EXPERIMENTAL

EGD-assisted administration of colonoscopy prep

Intervention Type PROCEDURE

Interventional group receive the first 2 liters of prep solution during EGD through the scope channel if colonoscopy expected the following day.

Standard Colonoscopy Prep

Split-dose polyethylene glycol (2 liters pm prior to colonoscopy, 1 liter 4 hours prior to colonoscopy)), clear liquid diet, metoclopramide 10 mg IV 30 minutes prior to procedure, tap water enema 1 hr prior to colonoscopy

Group Type ACTIVE_COMPARATOR

Control Group received standard prep by oral administration

Intervention Type PROCEDURE

Control group receive standard oral colonoscopy prep.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EGD-assisted administration of colonoscopy prep

Interventional group receive the first 2 liters of prep solution during EGD through the scope channel if colonoscopy expected the following day.

Intervention Type PROCEDURE

Control Group received standard prep by oral administration

Control group receive standard oral colonoscopy prep.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* hospitalized patients
* having EGD and expected to have colonoscopy the following day
* written informed consent

Exclusion Criteria

* unable to tolerate EGD-assisted prep administration
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rockford Gastroenterology Associates

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert L. Barclay, MD

Role: PRINCIPAL_INVESTIGATOR

Rockford Gastroenterology Associates, University of Illinois College of Medicine, Rockford

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SwedishAmerican Hospital

Rockford, Illinois, United States

Site Status

St. Anthony Medical Center

Rockford, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EGD-assisted 2012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.